BeiGene, Ltd.
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.73 | -2.13 | -2.96 | -0.91 | 1.80 | 0.71 | 0.40 | 2.34 | 3.52 | 3.68 | 1.74 | 5.74 | 14.56 | |
| 0.20 | 0.23 | 0.24 | 0.24 | 0.68 | 0.47 | 0.30 | 0.32 | 0.33 | 1.85 | 0.36 | 0.71 | 3.20 | |
| 0.90 | 0.89 | 0.85 | 1.25 | 1.10 | 1.01 | 0.86 | 1.34 | 1.23 | 6.67 | 1.07 | 2.25 | 11.07 | |
| -0.54 | 0.16 | -1.49 | -1.08 | 1.25 | -0.18 | -0.70 | 0.05 | 0.87 | 1.45 | -1.64 | -1.03 | -0.39 | |
| 1.70 | 1.60 | 1.85 | 1.05 | 1.28 | 0.87 | 1.05 | 0.57 | 0.42 | 2.52 | 0.35 | 0.59 | 3.83 | |
| -1.74 | -0.60 | -2.01 | -1.06 | -1.28 | -0.88 | -1.10 | -0.59 | -0.43 | -0.34 | -0.39 | -0.82 | -1.97 | |
| – | – | – | – | -0.03 | -0.13 | -0.87 | 0.23 | -0.04 | 0.70 | 0.44 | -0.15 | 0.94 | |
| -0.72 | 3.33 | 1.56 | 0.22 | 0.12 | -0.04 | -0.30 | 0.31 | 8.39 | 0.86 | 0.59 | 0.54 | 10.28 | |
| -3.19 | 1.01 | -3.63 | -1.81 | 0.91 | -0.70 | -0.97 | 2.26 | 11.57 | 4.40 | 2.11 | 5.79 | 23.65 | |
| -2.44 | -3.73 | -4.81 | -1.96 | 0.52 | -0.16 | -0.65 | 1.77 | 3.10 | 1.16 | 1.39 | 5.15 | 10.73 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.